Louis, United States), Precision Count BeadsTM (BioLegend, San Diego, United States), Fixation/Permeabilization Concentrate (Invitrogen, Carlsbad, United States), PercollTM (GE Healthcare, Little Chalfont, Buckinghamshire, UK), ACK lysing buffer (Gibco, Grand Island, United States), Triton X-100 (Sangon Biotech), Tissue-Tek O.C.T
Mechanistic Comparison# Dosing Comparison# Amycretin Dosing# Amycretin dosing is investigational: Subcutaneous: Once-weekly injection, doses up to 60 mg studied in phase 1b/2a over 36 weeks Oral: Daily tablet, doses up to 50 mg (or 2 x 50 mg) studied in phase 1 Phase 2 T2D: Both subcutaneous and oral formulations studied over 36 weeks Phase 3 dose selection will be informed by the completed phase 2 data
L-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders
Pharmacological significance of MitoQ in ameliorating mitochondria-related diseases
Exploring Computational Pharmaceutics AI and Modeling in Pharma 4.0 1st edn (Wiley, 2024)
Body protection compound 157